Pharmacotherapy of Autism Spectrum Disorder: Randomized BAART Clinical Trial

<div id="description" class= "segment s bg-color-white darken1 group"> <div>We review the BAART trial on risperidone vs aripiprazole in irritability associated with autism spectrum disorder.</div> </div> <div id="author" class="segment s bg-color-white darken1 group"> <div class="avatar s inline linked"> </div> </div> <ul> <li><a href= "https://psychopharmacologyinstitute.com/publication/pharmacotherapy-of-autism-spectrum-disorder-randomized-baart-clinical-trial-2588?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC041"> <strong>Download a PDF of this interview here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC041"> <strong>Become a premium member of the Psychopharmacology Institute</strong></a></li> </ul>